Jonathan J. Hollick

887 total citations
14 papers, 703 citations indexed

About

Jonathan J. Hollick is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Jonathan J. Hollick has authored 14 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Cell Biology. Recurrent topics in Jonathan J. Hollick's work include Cancer-related Molecular Pathways (4 papers), Microtubule and mitosis dynamics (4 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Jonathan J. Hollick is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Microtubule and mitosis dynamics (4 papers) and Sirtuins and Resveratrol in Medicine (3 papers). Jonathan J. Hollick collaborates with scholars based in United Kingdom, United States and Australia. Jonathan J. Hollick's co-authors include Nicholas J. Westwood, Sonia Laı́n, Anna R. McCarthy, David P. Lane, Julie A. Woods, Oliver Staples, Johanna Campbell, Maureen Higgins, Virginia Appleyard and Lee D. Baker and has published in prestigious journals such as Cancer Cell, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Jonathan J. Hollick

13 papers receiving 694 citations

Peers

Countries citing papers authored by Jonathan J. Hollick

Since Specialization

Citations

This map shows the geographic impact of Jonathan J. Hollick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan J. Hollick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan J. Hollick more than expected).

Fields of papers citing papers by Jonathan J. Hollick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan J. Hollick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan J. Hollick. The network helps show where Jonathan J. Hollick may publish in the future.

Co-authorship network of co-authors of Jonathan J. Hollick

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan J. Hollick. A scholar is included among the top collaborators of Jonathan J. Hollick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan J. Hollick. Jonathan J. Hollick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Lipid-Modulated, Graduated Inhibition of N-Glycosylation Pathway Priming Suggests Wide Tolerance of ER Proteostasis to Stress 2024 ·ACS Central Science ·Andrew M. Giltrap, Norman Morris, Yin Yao Dong, Stephen A. Cochrane, Thomas M. Krülle, (unknown), (unknown), Carina Wollnik, Timea Palmai‐Pallag, Elisabeth P. Carpenter, Jonathan J. Hollick, (unknown), York Rudhard, Benjamin G. Davis	2
2	Abstract 4178: The novel PLK1 inhibitor, CYC140: Identification of pharmacodynamic markers, sensitive target indications and potential combinations 2017 ·Cancer Research ·(unknown), Craig MacKay, (unknown), Elizabeth Pöhler, Karin Kroboth, Jonathan J. Hollick, Daniella Zheleva, Sheelagh Frame, David Blake	0
3	Therapeutic potential of novel PLK1 inhibitor CYC140 in esophageal cancer and acute leukemia 2016 ·European Journal of Cancer ·(unknown), Elizabeth Pöhler, Karin Kroboth, (unknown), Charles R. Mackay, Jonathan J. Hollick, Daniella Zheleva, (unknown), (unknown)	2
4	Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins 2012 ·Bioorganic & Medicinal Chemistry ·Anna R. McCarthy, Lisa Pirrie, Jonathan J. Hollick, Sébastien Ronseaux, Johanna Campbell, Maureen Higgins, Oliver Staples, Fanny Tran, Alexandra M. Z. Slawin, Sonia Laı́n, Nicholas J. Westwood	50
5	Abstract 2814: Potent and selective small molecule inhibitors of polo-like kinase 1: Biological characterization 2012 ·Cancer Research ·Sheelagh Frame, (unknown), (unknown), Jonathan J. Hollick, Stephen S. Taylor, Ted R. Hupp, David Blake, Daniella Zheleva	8
6	The discovery of nongenotoxic activators of p53: Building on a cell-based high-throughput screen 2010 ·Seminars in Cancer Biology ·Anna R. McCarthy, Jonathan J. Hollick, Nicholas J. Westwood	9
7	Synthesis and biological evaluation of functionalised tetrahydro-β-carboline analogues as inhibitors of Toxoplasma gondii invasion 2009 ·Organic & Biomolecular Chemistry ·(unknown), Stephen Patterson, (unknown), (unknown), Jonathan J. Hollick, Alexandra M. Z. Slawin, Gary E. Ward, Nicholas J. Westwood	13
8	Characterization, chemical optimization and anti-tumor activity of a tubulin poison identified by a p53-based phenotypic screen 2008 ·Cell Cycle ·Oliver Staples, Jonathan J. Hollick, Johanna Campbell, Maureen Higgins, Anna R. McCarthy, Virginia Appleyard, Karen Murray, Lee D. Baker, Alastair M. Thompson, Sébastien Ronseaux, Alexandra M. Z. Slawin, David P. Lane, Nicholas J. Westwood, Sonia Laı́n	12
9	Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator 2008 ·Cancer Cell ·Sonia Laı́n, Jonathan J. Hollick, Johanna Campbell, Oliver Staples, Maureen Higgins, Mustapha Aoubala, Anna R. McCarthy, Virginia Appleyard, Karen Murray, Lee D. Baker, Alastair M. Thompson, Joanne Mathers, Stephen J. Holland, Michael J. R. Stark, G. J. Pass, Julie A. Woods, David P. Lane, Nicholas J. Westwood	419
10	Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator 2007 ·Molecular Cancer Therapeutics ·Sonia Laı́n, Jonathan J. Hollick, Johanna Campbell, Oliver Staples, Maureen Higgins, Mustapha Aoubala, Anna R. McCarthy, Virginia Appleyard, Karen Murray, (unknown), Joanne Mathers, (unknown), (unknown), Julie A. Woods, David P. Lane, Nicholas J. Westwood	3
11	Pyranone, Thiopyranone, and Pyridone Inhibitors of Phosphatidylinositol 3-Kinase Related Kinases. Structure−Activity Relationships for DNA-Dependent Protein Kinase Inhibition, and Identification of the First Potent and Selective Inhibitor of the Ataxia Telangiectasia Mutated Kinase 2007 ·Journal of Medicinal Chemistry ·Jonathan J. Hollick, Laurent Rigoreau, Céline Cano, Xiaoling Cockcroft, Nicola J. Curtin, Mark Frigerio, Bernard T. Golding, (unknown), Ian R. Hardcastle, Ian Hickson, Marc Hummersone, Keith Menear, Niall M.B. Martin, Ian Matthews, David R. Newell, (unknown), Caroline J. Richardson, Graeme C.M. Smith, Roger J. Griffin	61
12	Pilot screening programme for small molecule activators of p53 2005 ·International Journal of Cancer ·(unknown), Jonathan J. Hollick, Nicholas J. Westwood, Julie A. Woods, David P. Lane, Sonia Laı́n	39
13	2,6-Disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-Dependent protein kinase (DNA-PK) 2003 ·Bioorganic & Medicinal Chemistry Letters ·Jonathan J. Hollick, Bernard T. Golding, Ian R. Hardcastle, Niall M.B. Martin, Caroline J. Richardson, Laurent Rigoreau, Graeme C.M. Smith, Roger J. Griffin	83
14	2,6‐Disubstituted Pyran‐4‐one and Thiopyran‐4‐one Inhibitors of DNA‐Dependent Protein Kinase (DNA‐PK). 2003 ·ChemInform ·Jonathan J. Hollick, Bernard T. Golding, Ian R. Hardcastle, Niall M.B. Martin, Caroline J. Richardson, Laurent Rigoreau, Graeme C.M. Smith, Roger J. Griffin	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact